1-5 of 5
Anne Monks
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Transcriptional Profiling Identifies Altered Intracellular Labile Iron Homeostasis as a Contributing Factor to the Toxicity of Adaphostin: Decreased Vascular Endothelial Growth Factor Secretion Is Independent of Hypoxia-Inducible Factor-1 Regulation

Free
Curtis Hose, Gurmeet Kaur, Edward A. Sausville, Anne Monks
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (17): 6370–6381.
https://doi.org/10.1158/1078-0432.CCR-05-0291
Published: 06 September 2005
View articletitled, Transcriptional Profiling Identifies Altered Intracellular Labile Iron Homeostasis as a Contributing Factor to the Toxicity of Adaphostin: Decreased Vascular Endothelial Growth Factor Secretion Is Independent of Hypoxia-Inducible Factor-1 Regulation
Open the PDF for Transcriptional Profiling Identifies Altered Intracellular Labile Iron Homeostasis as a Contributing Factor to the Toxicity of Adaphostin: Decreased Vascular Endothelial Growth Factor Secretion Is Independent of Hypoxia-Inducible Factor-1 Regulation in another window
Journal Articles

Components of the Cell Death Machine and Drug Sensitivity of the National Cancer Institute Cell Line Panel

Free
Phyllis A. Svingen, David Loegering, Joe Rodriquez, Xue Wei Meng, Peter W. Mesner, Jr., Susan Holbeck, Anne Monks, Stan Krajewski, Dominic A. Scudiero, Edward A. Sausville, John C. Reed, Yuri A. Lazebnik, Scott H. Kaufmann
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (20): 6807–6820.
https://doi.org/10.1158/1078-0432.CCR-0778-02
Published: 22 October 2004
View articletitled, Components of the Cell Death Machine and Drug Sensitivity of the National Cancer Institute Cell Line Panel
Open the PDF for Components of the Cell Death Machine and Drug Sensitivity of the National Cancer Institute Cell Line Panel in another window
Journal Articles

Thymidine Kinase, Thymidylate Synthase, and Dihydropyrimidine Dehydrogenase Profiles of Cell Lines of the National Cancer Institute’s Anticancer Drug Screen

Free
Jean L. Grem, Kathleen D. Danenberg, Katherine Behan, Allyson Parr, Lauren Young, Peter V. Danenberg, Diana Nguyen, James Drake, Anne Monks, Carmen J. Allegra
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (4): 999–1009.
Published: 01 April 2001
View articletitled, Thymidine Kinase, Thymidylate Synthase, and Dihydropyrimidine Dehydrogenase Profiles of Cell Lines of the National Cancer Institute’s Anticancer Drug Screen
Open the PDF for Thymidine Kinase, Thymidylate Synthase, and Dihydropyrimidine Dehydrogenase Profiles of Cell Lines of the National Cancer Institute’s Anticancer Drug Screen in another window
Journal Articles

Expression and Prognostic Significance of IAP-Family Genes in Human Cancers and Myeloid Leukemias

Free
Ingo Tamm, Steven M. Kornblau, Harry Segall, Stanislaw Krajewski, Kate Welsh, Shinichi Kitada, Dominic A. Scudiero, Gabriela Tudor, Yi Hua Qui, Anne Monks, Michael Andreeff, John C. Reed
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (5): 1796–1803.
Published: 01 May 2000
View articletitled, Expression and Prognostic Significance of IAP-Family Genes in Human Cancers and Myeloid Leukemias
Open the PDF for Expression and Prognostic Significance of IAP-Family Genes in Human Cancers and Myeloid Leukemias in another window
Journal Articles

Modulation of Clinical Drug Resistance in a B Cell Lymphoma Patient by the Protein Kinase Inhibitor 7-Hydroxystaurosporine: Presentation of a Novel Therapeutic Paradigm

Free
Wyndham H. Wilson, Lynn Sorbara, William D. Figg, Erik K. Mont, Edward Sausville, Katherine E. Warren, Frank M. Balis, Ken Bauer, Mark Raffeld, Adrian M. Senderowicz, Anne Monks
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (2): 415–421.
Published: 01 February 2000
View articletitled, Modulation of Clinical Drug Resistance in a B Cell Lymphoma Patient by the Protein Kinase Inhibitor 7-Hydroxystaurosporine: Presentation of a Novel Therapeutic Paradigm
Open the PDF for Modulation of Clinical Drug Resistance in a B Cell Lymphoma Patient by the Protein Kinase Inhibitor 7-Hydroxystaurosporine: Presentation of a Novel Therapeutic Paradigm in another window